title: Differential effects of leptin receptor mutation on male and female BBDR Gimap5-/Gimap5- spontaneously diabetic rats.
abstract: Rodents homozygous for autosomal leptin receptor gene mutations not only become obese, insulin resistant, and hyperleptinemic but also develop a dysregulated immune system. Using marker-assisted breeding to introgress the Koletsky rat leptin receptor mutant (lepr-/lepr-), we developed a novel congenic BBDR.(lepr-/lepr-) rat line to study the development of obesity and type 2 diabetes (T2D) in the BioBreeding (BB) diabetes-resistant (DR) rat. While heterozygous lepr (-/+) or homozygous (+/+) BBDR rats remained lean and metabolically normal, at 3 wk of age all BBDR.(lepr-/lepr-) rats were obese without hyperglycemia. Between 45 and 70 days of age, male but not female obese rats developed T2D. We had previously developed congenic BBDR.(Gimap5-/Gimap5-) rats, which carry an autosomal frameshift mutation in the Gimap5 gene linked to lymphopenia and spontaneous development of type 1 diabetes (T1D) without sex differences. Because the autoimmune-mediated destruction of pancreatic islet beta-cells may be affected not only by obesity but also by the absence of leptin receptor signaling, we next generated BBDR.(lepr-/lepr-,Gimap5-/Gimap5-) double congenic rats carrying the mutation for Gimap5 and T1D as well as the Lepr mutation for obesity and T2D. The hyperleptinemia rescued end-stage islets in BBDR.(lepr-/lepr-,Gimap5-/Gimap5-) congenic rats and induced an increase in islet size in both sexes, while T1D development was delayed and reduced only in females. These results demonstrate that obesity and T2D induced by introgression of the Koletsky leptin receptor mutation in the BBDR rat result in islet expansion associated with protection from T1D in female but not male BBDR.(lepr-/lepr-,Gimap5-/Gimap5-) congenic rats. BBDR.(lepr-/lepr-,Gimap5-/Gimap5-) congenic rats should prove valuable to study interactions between lack of leptin receptor signaling, obesity, and sex-specific T2D and T1D.
authors.affiliation: Departments of Comparative Medicine, University of Washington, Seattle, Washington 98195, USA. moralejo@u.washington.edu
authors.forename: Daniel H
authors.initials: DH
authors.lastname: Moralejo
authors.forename: Carl T
authors.initials: CT
authors.lastname: Hansen
authors.forename: Piper
authors.initials: P
authors.lastname: Treuting
authors.forename: Martin J
authors.initials: MJ
authors.lastname: Hessner
authors.forename: Jessica M
authors.initials: JM
authors.lastname: Fuller
authors.forename: Brian
authors.initials: B
authors.lastname: Van Yserloo
authors.forename: Richard
authors.initials: R
authors.lastname: Jensen
authors.forename: William
authors.initials: W
authors.lastname: Osborne
authors.forename: Anne E
authors.initials: AE
authors.lastname: Kwitek
authors.forename: Ake
authors.initials: A
authors.lastname: Lernmark
mesh_terms: D054392:Adipokines / Q000097:blood; D050154:Adiposity; D000818:Animals; D020296:Animals, Congenic; D001772:Blood Cell Count; D001786:Blood Glucose / Q000378:metabolism; D001835:Body Weight; D001947:Breeding; D033481:Chromosomes, Mammalian / Q000235:genetics; D016207:Cytokines / Q000097:blood; D003921:Diabetes Mellitus, Experimental / Q000097:blood / Q000150:complications / Q000235:genetics* / Q000473:pathology; D005260:Female; D019204:GTP-Binding Proteins / Q000172:deficiency* / Q000378:metabolism; D005838:Genotype; D006943:Hyperglycemia / Q000097:blood / Q000150:complications / Q000473:pathology; D008297:Male; D009154:Mutation / Q000235:genetics*; D009765:Obesity / Q000097:blood / Q000150:complications / Q000473:pathology; D010179:Pancreas / Q000378:metabolism / Q000473:pathology; D010641:Phenotype; D051381:Rats; D054411:Receptors, Leptin / Q000235:genetics* / Q000378:metabolism; D012727:Sex Characteristics; D016019:Survival Analysis; D013997:Time Factors
chemical_list: D054392:Adipokines; D001786:Blood Glucose; D016207:Cytokines; D054411:Receptors, Leptin; D019204:GTP-Binding Proteins; C494977:Gimap5 protein, rat